Completed
A Study to Evaluate the Efficacy and Safety of Dupilumab in Adult Patients With Bullous Pemphigoid
NCT04206553
- Conditions
- Autoimmune Diseases, Bullous Pemphigoid, Immune System Diseases, +4 more
- Locations
-
- Regeneron study Site Birmingham, Alabama, United States
- Regeneron Study Site Scottsdale, Arizona, United States
- Regeneron Study Site Redwood City, California, United States
- Regeneron Study Site Farmington, Connecticut, United States